Literature DB >> 15150762

Identifying specific conformations by using a carbohydrate scaffold: discovery of subtype-selective LPA-receptor agonists and an antagonist.

Yoko Tamaruya1, Masato Suzuki, Goshu Kamura, Motomu Kanai, Kotaro Hama, Kumiko Shimizu, Junken Aoki, Hiroyuki Arai, Masakatsu Shibasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15150762     DOI： 10.1002/anie.200454065

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  10 in total

Review 1.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.

Authors:  Dong-Soon Im
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

3.  Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.

Authors:  Peng Cui; Jose L Tomsig; William F McCalmont; Sangderk Lee; Christopher J Becker; Kevin R Lynch; Timothy L Macdonald
Journal:  Bioorg Med Chem Lett       Date:  2007-01-13       Impact factor: 2.823

4.  Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.

Authors:  Guo Li; Philip D Mosier; Xianjun Fang; Yan Zhang
Journal:  J Mol Graph Model       Date:  2009-04-19       Impact factor: 2.518

5.  LPA1 receptor-mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.

Authors:  Péter Tibor Dancs; Éva Ruisanchez; Andrea Balogh; Cecília Rita Panta; Zsuzsanna Miklós; Rolf M Nüsing; Junken Aoki; Jerold Chun; Stefan Offermanns; Gábor Tigyi; Zoltán Benyó
Journal:  FASEB J       Date:  2017-01-09       Impact factor: 5.191

6.  Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA.

Authors:  Guowei Jiang; Yong Xu; Yuko Fujiwara; Tamotsu Tsukahara; Ryoko Tsukahara; Joanna Gajewiak; Gabor Tigyi; Glenn D Prestwich
Journal:  ChemMedChem       Date:  2007-05       Impact factor: 3.466

Review 7.  LPA receptor signaling: pharmacology, physiology, and pathophysiology.

Authors:  Yun C Yung; Nicole C Stoddard; Jerold Chun
Journal:  J Lipid Res       Date:  2014-03-18       Impact factor: 5.922

8.  Autotaxin-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary controls decidualization pathways.

Authors:  Shizu Aikawa; Kuniyuki Kano; Asuka Inoue; Jiao Wang; Daisuke Saigusa; Takeshi Nagamatsu; Yasushi Hirota; Tomoyuki Fujii; Soken Tsuchiya; Yoshitaka Taketomi; Yukihiko Sugimoto; Makoto Murakami; Makoto Arita; Makoto Kurano; Hitoshi Ikeda; Yutaka Yatomi; Jerold Chun; Junken Aoki
Journal:  EMBO J       Date:  2017-06-06       Impact factor: 11.598

9.  Molecular mechanism of lysophosphatidic acid-induced hypertensive response.

Authors:  Kuniyuki Kano; Hirotaka Matsumoto; Asuka Inoue; Hiroshi Yukiura; Motomu Kanai; Jerold Chun; Satoshi Ishii; Takao Shimizu; Junken Aoki
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

10.  G-Protein Coupled Receptor Dysregulation May Play Roles in Severe Preeclampsia-A Weighted Gene Correlation Network Analysis of Placental Gene Expression Profile.

Authors:  Manuel S Vidal; Christian Deo T Deguit; Gracia Fe B Yu; Melissa D Amosco
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.